Tests that capture tumour signatures in the blood have the potential to detect cancer before symptoms appear.

Scientists hope that if software passes trials it could boost screening rates

The same technique could also be used to diagnose other types of cancer

A novel urine test may detect bladder cancer earlier than available methods, according to study results published in Cancer Discovery. Maximilian Diehn, MD, PhD, associate professor of radiation oncology at Stanford University, and colleagues developed a high-throughput sequencing-based hybrid capture method for urine tumor DNA detection.

A conversation with Maximilian Diehn, MD, PhD, associate professor of radiation oncology at Stanford University

Researchers at the School of Medicine have developed a highly sensitive urine test for diagnosing and monitoring bladder cancer.

Researchers work to fine-tune a test that could better detect lingering disease in cancer patients.

A blood test can predict which patients with a type of cancer called diffuse large B cell lymphoma are likely to respond positively to initial therapy and which are likely to need more aggressive treatment, according to a multicenter study led by researchers at the Stanford University School of Medicine.

When James Spudich was diagnosed with lung cancer, researchers had a rare, and unexpected, opportunity to study healthy and diseased human tissue at an unprecedented level of detail.

(Inside Science) -- When lung cancer is caught in its earliest stages, before the tumors have spread to other organs, people face the prospect of radiation, chemo, surgery or some combination of the three, and for many, outcomes are good.

Maximilian Diehn, MD, PhD, discussed the future of NGS platforms and liquid biopsies and his vision for them eventually becoming standard practice for patients with lung cancer.

Running low on talking points for your liquid biopsy watercooler chats? Fear not. An education session at ASCO 2017 highlighted some of the latest findings from the field — and we have a recap of that recap here.

Roche has licensed and plans to commercialize the circulating tumor DNA technology, which the Stanford researchers dubbed CAPP-seq.

Sequencing tiny bits of DNA circulating in the blood of patients with lymphoma can accurately identify the cancer subtype and pinpoint mutations that might cause drug resistance, according to researchers.

Pathway is one of a growing number of start-ups aiming to sell blood tests and other types of medical lab checks directly to consumers.

Soon, blood tests could reveal whether a person has cancer—and tell doctors the best way to treat it.

Researchers believe painful biopsies could be replaced with a simple blood tests, ending the painful tests for many

The group combined molecular barcoding and an error suppression computational method to enable the detection of mutations at a .004 percent frequency. 

Researchers have designed new strategies to distinguish true variants from errors when trying to call very low frequency mutations in circulating tumor DNA.

During an episode in this season of Keeping Up With the Kardashians, Kris Jenner made her daughters do a DNA-based cancer screening test.

Maximilian Diehn, MD, PhD, an assistant professor in the Department of Radiation Oncology, Stanford Medicine, discusses some of the next steps researchers are taking with liquid biopsies in the field of lung cancer.

This peer-to-peer exchange highlights results of a study that tested whether analyzing circulating tumor DNA (ctDNA) during treatment with chemoradiotherapy could predict outcomes in patients with localized lung cancer.

The Pathway Genomics–created cancer test that was featured on 'Keeping Up With the Kardashians' is being investigated by CBS News for possibly promising patients more than current medical science can deliver — details

Pathway Genomics claims its liquid biopsy can detect cancer before patient shows symptoms - but expert says that promise is "years away"

Stanford researchers are able to find and analyze DNA that cancer cells shed into the bloodstream, offering them a way to monitor the progress of anticancer therapy,…